Seq |
Description |
Document |
Type |
Size |
1 |
ANNUAL REPORT |
ea0202988-10k_biomx.htm iXBRL |
10-K |
1641334 |
2 |
DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EX |
ea020298801ex4-1_biomx.htm |
EX-4.1 |
32015 |
3 |
FORM OF INDEMNIFICATION AGREEMENT |
ea020298801ex10-3_biomx.htm |
EX-10.3 |
77487 |
4 |
EXCLUSIVE LICENSE BETWEEN ADAPTIVE PHAGE THERAPEUTICS, INC. AND UNITED STATES OF |
ea020298801ex10-22_biomx.htm |
EX-10.22 |
83029 |
5 |
FIRST AMENDMENT, DATED JANUARY 10, 2019, TO EXCLUSIVE LICENSE BETWEEN ADAPTIVE P |
ea020298801ex10-23_biomx.htm |
EX-10.23 |
14845 |
6 |
NON-EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN ADAPTIVE PHAGE THERAPEUTICS, INC. |
ea020298801ex10-24_biomx.htm |
EX-10.24 |
78243 |
7 |
LICENSE MODIFICATION 1, DATED AUGUST 31, 2022, TO NON-EXCLUSIVE LICENSE AGREEMEN |
ea020298801ex10-25_biomx.htm |
EX-10.25 |
13922 |
8 |
LEASE AGREEMENT, DATED AS OF AUGUST 9, 2019, BY AND BETWEEN ARE-708 QUINCE ORCHA |
ea020298801ex10-28_biomx.htm |
EX-10.28 |
261221 |
9 |
AMENDMENT NO. 1, DATED AS OF OCTOBER 28, 2020, TO LEASE AGREEMENT BY AND BETWEEN |
ea020298801ex10-29_biomx.htm |
EX-10.29 |
50210 |
10 |
AMENDMENT NO. 2, DATED AS OF JULY 8, 2021, TO LEASE AGREEMENT BY AND BETWEEN ARE |
ea020298801ex10-30_biomx.htm |
EX-10.30 |
51913 |
11 |
AMENDMENT NO. 3, DATED AS OF JULY 15, 2021, TO LEASE AGREEMENT BY AND BETWEEN AR |
ea020298801ex10-31_biomx.htm |
EX-10.31 |
40129 |
12 |
AMENDMENT NO. 4, DATED AS OF SEPTEMBER 27, 2022, TO LEASE AGREEMENT BY AND BETWE |
ea020298801ex10-32_biomx.htm |
EX-10.32 |
40477 |
13 |
AMENDMENT NO. 5, DATED AS OF FEBRUARY 2, 2023, TO LEASE AGREEMENT BY AND BETWEEN |
ea020298801ex10-33_biomx.htm |
EX-10.33 |
18005 |
14 |
AMENDMENT NO. 6, DATED AS OF MARCH 5, 2024, TO LEASE AGREEMENT BY AND BETWEEN AR |
ea020298801ex10-34_biomx.htm |
EX-10.34 |
165721 |
15 |
SUBSIDIARIES OF COMPANY |
ea020298801ex21-1_biomx.htm |
EX-21.1 |
1990 |
16 |
CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER |
ea020298801ex23-1_biomx.htm |
EX-23.1 |
2327 |
17 |
CERTIFICATION |
ea020298801ex31-1_biomx.htm |
EX-31.1 |
16481 |
18 |
CERTIFICATION |
ea020298801ex31-2_biomx.htm |
EX-31.2 |
16416 |
19 |
CERTIFICATION |
ea020298801ex32-1_biomx.htm |
EX-32.1 |
9054 |
20 |
CLAWBACK POLICY |
ea020298801ex97-1_biomx.htm |
EX-97.1 |
40273 |
21 |
RESOLUTIONS OF BOARD OF DIRECTORS RATIFYING STOCK ISSUANCE |
ea020298801ex99-1_biomx.htm |
EX-99.1 |
7639 |
27 |
GRAPHIC |
image_001.jpg |
GRAPHIC |
38645 |
28 |
GRAPHIC |
logo_001.jpg |
GRAPHIC |
5332 |
29 |
GRAPHIC |
ex10-24_001.jpg |
GRAPHIC |
4185 |
30 |
GRAPHIC |
ex10-24_002.jpg |
GRAPHIC |
2404 |
31 |
GRAPHIC |
ex10-24_004.jpg |
GRAPHIC |
1350 |
32 |
GRAPHIC |
ex10-24_005.jpg |
GRAPHIC |
2151 |
33 |
GRAPHIC |
ex10-24_006.jpg |
GRAPHIC |
8274 |
34 |
GRAPHIC |
ex10-25_001.jpg |
GRAPHIC |
5294 |
35 |
GRAPHIC |
ex10-25_002.jpg |
GRAPHIC |
3444 |
|
Complete submission text file |
0001213900-24-030053.txt |
|
8967573 |